FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.’s Wishes

The New York Times – Business:

The peptides, which are increasingly marketed as providing longevity and health benefits, were removed in 2023 from the agency’s list of products that compounding pharmacies can sell.

Author: RSS Feed

This post first appeared in The New York Times – Business. Read the original article.